7 results
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... for the Management ... with ‘treatment ... and 5.4 #EBM #Management ... #Pharmacology #
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
ACLF) Clinical Guidelines ... those with CLD (± cirrhosis ... months without treatment ... #Hepatology #gastroenterology ... #management #diagnosis
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... decisionaid #cardiology #hematology
Hepatitis B - Treatment Indications
Treatment not indicated:
 • Immune tolerant state - HBe-Ag detectable, high HBV
Presence of CP or PC ... Family history of cirrhosis ... or fibrosis • Cirrhosis ... #Indications #management ... #hepatology
Hepatic Encephalopathy - Diagnosis and Management Summary
Definition:
 • Alteration in brain function manifested by neuropsychiatric symptoms
Diagnosis and Management ... Prevalence: At cirrhosis ... colonic bacteria • Guidelines ... Classification #Diagnosis #Management ... #treatment #hepatology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
Clinical Practice Guideline ... First Line Treatment ... Function Second Line Treatment ... #Management #Hepatology ... Gastroenterology #oncology #Pharmacology
Primary Biliary Cirrhosis - Management
A. Initiate therapy 
 - Initiate 1st line therapy with UDCA (13-15
Primary Biliary Cirrhosis ... survey disease #PBC ... Primary #Biliary #Cirrhosis ... #Management #Treatment ... #hepatology